Edwards Lifesciences Japan — Cost of Sales increased by 8.3% to $14.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.3%, from $12.30M to $14.30M. Over 3 years (FY 2022 to FY 2025), Japan — Cost of Sales shows an upward trend with a 8.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease relative to sales suggests improved operational efficiency or favorable product mix, while an increase may signal rising production or logistics costs.
This metric captures the direct costs associated with producing and delivering medical devices sold within the Japanese...
Standard cost of goods sold (COGS) metric for regional segments in the medical technology industry.
ew_segment_japan_cost_of_sales| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.38M | $10.38M | $10.38M | $10.38M | $11.65M | $11.65M | $11.65M | $11.65M | $11.80M | $12.60M | $11.70M | $12.00M | $12.30M | $13.60M | $13.30M | $13.20M | $14.30M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +12.3% | +0.0% | +0.0% | +0.0% | +1.3% | +6.8% | -7.1% | +2.6% | +2.5% | +10.6% | -2.2% | -0.8% | +8.3% |
| YoY Change | — | — | — | — | +12.3% | +12.3% | +12.3% | +12.3% | +1.3% | +8.2% | +0.4% | +3.0% | +4.2% | +7.9% | +13.7% | +10.0% | +16.3% |